Trial Profile
An open label pilot study of guanfacine extended release in children and adolescents with traumatic stress related symptoms
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Dec 2015
Price :
$35
*
At a glance
- Drugs Guanfacine (Primary)
- Indications Attention-deficit hyperactivity disorder; Post-traumatic stress disorders; Traumatic stress disorders
- Focus Therapeutic Use
- 01 Dec 2015 New trial record